FXA (TM)— 510(k) K110765

Name: FDA 510(k) clearance K110765
Creator: U.S. Food and Drug Administration
Published: 2011-11-04

Substantially Equivalent

Aces GmbH

FDA 510(k) clearance K110765 for FXA (TM), Substantially Equivalent on 2011-11-04. Applicant: Aces GmbH. Device class: 2.

Clearance details

Applicant: Aces GmbH
Product code: Code LLZ
Device class: Class 2
Regulation: 21 CFR 892.2050
Advisory panel: Radiology
Date received: 2011-03-18
Decision date: 2011-11-04
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Filderstadt, Bw, DE

Download summary PDF View on FDA.gov ↗

Recent devices under product code LLZ

view all

K262060 — 3D-RD-S2026-09-04
K261500 — KBA3D (v2.4.0)2026-08-17
K262449 — AdvaView2026-08-14
K261916 — NeuroQuant PET2026-08-12
K260936 — RadioViewAI2026-07-31

Adverse events under product code LLZ

product code LLZ

Death: 13
Total: 13

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.